Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health Corporation reported second-quarter results for the period ending June 30, 2022, with total revenues of $80.6 billion, an 11% increase year-over-year. GAAP diluted EPS rose to $2.23, while adjusted EPS slightly decreased to $2.40. Operating income achieved $4.6 billion, supported by a $225 million gain from the sale of PayFlex. Full-year guidance for 2022 includes a raised GAAP EPS range of $7.23 to $7.43 and cash flow from operations guidance of $12.5 to $13.5 billion. The company remains focused on expanding health services amidst economic challenges.
CVS Health will host a conference call for analysts and investors on August 3, 2022, at 8:00 a.m. ET to discuss its second quarter 2022 financial results. The call will be accessible via an audio webcast on the CVS Health Investor Relations website, where it will be archived for one year. CVS Health is a leading health solutions company dedicated to improving community health through its extensive services and workforce, including over 40,000 healthcare professionals.
The 2022 Health Care Insights Study by CVS Health reveals a shift in U.S. consumer attitudes towards healthcare post-COVID-19. Conducted with 1,000 consumers and 400 providers, the study indicates that over 81% of consumers value their provider's awareness of life satisfaction. A significant 83% emphasize integrated care coordination. Virtual visits have become crucial, with 92% of participants considering convenience key to provider selection. Trust in healthcare providers has strengthened, with 44% of consumers expressing greater appreciation than pre-pandemic.
CVS Health has appointed Tilak Mandadi as Executive Vice President and Chief Data, Digital and Technology Officer, effective July 25. He will oversee the company's digital strategy and aim to enhance consumer-focused experiences. Mandadi, previously with MGM Resorts International, brings extensive experience from Disney and American Express. CVS serves over 44 million unique digital customers and aims to integrate digital solutions to improve the health care experience. This move underscores CVS's commitment to utilizing technology for growth and customer engagement.
CVS Health (NYSE: CVS) has approved a quarterly dividend of $0.55 per share on its Common Stock. The payment is scheduled for August 1, 2022, to shareholders on record as of July 22, 2022. CVS Health, a leading health solutions company, operates with a workforce of over 300,000 employees, including 40,000 healthcare professionals. The company focuses on enhancing access to healthcare and lowering costs for communities across America.
Aetna Better Health of Kansas, a CVS Health company, announced a donation of $125,000 to support community health initiatives across Kansas. This funding will assist five local organizations addressing critical health and social care needs, including mental health and housing. Since 2021, Aetna has contributed over $330,000 to various community organizations in the state. The aim of these donations is to enhance access to care and improve well-being for underserved populations in Kansas.
CVS Health (NYSE: CVS) announced that Shawn Guertin, Executive Vice President and Chief Financial Officer, will participate in a fireside chat with investors at the Goldman Sachs Global Healthcare Conference on June 15, 2022, at approximately 8:00 am Pacific Time. An audio webcast of this event will be available on the CVS Health Investor Relations website and archived for one year. CVS Health provides diverse health solutions, improving community health across America through a strong workforce and various services.
Summary not available.
Summary not available.
CVS Health (NYSE: CVS) announced that Executive Vice President and CFO Shawn Guertin will participate in a fireside chat at the Bank of America Healthcare Conference on May 12, 2022, at 8:40 am Pacific Time. The event will be available via an audio webcast on the Investor Relations section of the CVS Health website, where it will be archived for one year. CVS Health is a top health solutions company, emphasizing affordable health services and community engagement through over 300,000 employees.